Discover trends, market shifts, and competitive outlooks for the buccal drug delivery system industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
#What is the Anticipated CAGR of the Buccal Drug Delivery System Market, and What Factors Will Drive It?
The market for buccal drug delivery systems has seen rapid expansion in the recent past. The market, which was valued at $3.55 billion in 2024, is predicted to rise to $3.91 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.3%. This growth during the historical period can be linked to factors such as early innovations in drug delivery, uptake by the pharmaceutical sector, impactful clinical research, effective market infiltration techniques, and the system’s application for disease-specific treatments.
The market size of the buccal drug delivery system is projected to experience significant expansion in the coming years, anticipated to reach $5.97 billion in 2029 with a compound annual growth rate (CAGR) of 11.1%. The projected growth during this period can be linked to several factors such as the focus on patient-oriented drug delivery, the increase in the elderly population, the demand for targeted treatment methods, the delivery of biologics and peptides, regulatory backing and approvals, and investment in research and development. Key trends during this forecast period will be patient comfort and adherence to treatment, breakthroughs in drug formulation, a rise in chronic diseases prevalence, focus on pediatric and geriatric care, and improved bioavailability.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8290&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Buccal Drug Delivery System Market?
The escalating incidence of long-term health conditions is predicted to drive the buccal drug delivery systems market’s expansion. Chronic diseases, which may last for a year or more, include conditions like heart disease, stroke, cancer, diabetes, and arthritis. These prevalent chronic illnesses need continuous nutrition and healthcare because they can be managed, but not cured. Buccal drug delivery systems offer a suitable and effective way of delivering mucosal and transmucosal medication, which is needed by numerous patients with chronic diseases such as cancer and diabetes. For example, in September 2023, the World Health Organization, a Switzerland-based United Nations specialized agency, reported that there were 41 million deaths caused by non-communicable diseases (NCDs) or chronic diseases each year worldwide, accounting for 74% of all deaths. These included 17.9 million from heart diseases, 9.3 million from cancers, 4.1 million from chronic respiratory diseases, and 2 million from diabetes. Consequently, the escalating incidence of chronic ailments is spurring the buccal drug delivery systems market’s growth.
Which Key Market Segments Comprise the Buccal Drug Delivery System Market and Drive Its Revenue Growth?
The buccal drug delivery system market covered in this report is segmented –
1) By Type: Sublingual, Buccal Tablets And Lozenges, Oral Sprays
2) By Application: Pain Management, Smoking Cessation, Angina Pectoris
3) By End-User: Hospitals, Ambulatory Centers, Other End-Users
Subsegments:
1) By Sublingual: Sublingual Tablets, Sublingual Films
2) By Buccal Tablets And Lozenges: Buccal Tablets, Buccal Lozenges
3) By Oral Sprays: Spray Solutions, Spray Gels
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=8290&type=smp
Which Areas Are Leading Regions in the Buccal Drug Delivery System Market Expansion Across the Globe?
North America was the largest region in the buccal drug delivery systems market share in 2024. The regions covered in the buccal drug delivery system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Strategic Trends Steering theBuccal Drug Delivery System Market Direction?
Key players in the buccal drug delivery systems market are concentrating on the creation of innovative solutions, such as oral medication for plaque psoriasis, in order to enhance patient results and boost drug delivery efficiency. Plaque psoriasis oral treatment involves the oral intake of drugs to control and reduce the symptoms of this chronic autoimmune disease, which causes quick skin cell growth leading to thick, red, scaly patches. For example, in September 2022, Bristol Myers Squibb, a pharmaceutical company based in the US, was granted FDA approval for Sotyktu (deucravacitinib), an oral therapy for adults suffering from moderate-to-severe plaque psoriasis. This approval represents the first new oral therapy for this condition in almost ten years, providing a unique mechanism of action as a selective inhibitor of tyrosine kinase 2 (TYK2).
View the full report here:
https://www.thebusinessresearchcompany.com/report/buccal-drug-delivery-system-global-market-report
How Is the Buccal Drug Delivery System Market Conceptually Defined?
The buccal drug delivery system refers to the injection of the desired medicine through the buccal mucosal membrane lining of the mouth cavity. This method is effective for administering mucosal and transmucosal drugs. Mucosal drug delivery aims for site-specific drug release on the mucosa, whereas transmucosal permeation entails drug absorption across the mucosal barrier and into the systemic circulation.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8290
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
